Λετονία - Λετονικά - Zāļu valsts aģentūra

sandoz d.d., slovenia - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg

Λετονία - Λετονικά - Zāļu valsts aģentūra

sandoz d.d., slovenia - dimetilfumarāts - zarnās šķīstošā kapsula, cietā - 120 mg

Λετονία - Λετονικά - Zāļu valsts aģentūra

sandoz d.d., slovenia - dimetilfumarāts - zarnās šķīstošā kapsula, cietā - 240 mg

Λετονία - Λετονικά - Zāļu valsts aģentūra

teva gmbh, germany - dimetilfumarāts - zarnās šķīstošā kapsula, cietā - 120 mg

Λετονία - Λετονικά - Zāļu valsts aģentūra

teva gmbh, germany - dimetilfumarāts - zarnās šķīstošā kapsula, cietā - 240 mg

Ευρωπαϊκή Ένωση - Λετονικά - EMA (European Medicines Agency)

sanofi winthrop industrie - isatuximab - multiple mieloma - antineoplastiski līdzekļi - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.

Ευρωπαϊκή Ένωση - Λετονικά - EMA (European Medicines Agency)

mylan ireland limited - dimethyl fumarate - multiplā skleroze, recidivējoši-pārskaitot - imūnsupresanti - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Ευρωπαϊκή Ένωση - Λετονικά - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - multiple mieloma - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Λετονία - Λετονικά - Zāļu valsts aģentūra

sanoswiss uab, lithuania - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/850 mg

Λετονία - Λετονικά - Zāļu valsts aģentūra

sanoswiss uab, lithuania - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg